← Back to Calendar
Live Company Data
NGM
Updated
22m ago
· Data: FMP
Current Price
$100.74
+126.43%
+$56.25 today
Day: $100.58 – $104.16
52-Week Range
Current price is at 89% of 52-week range
⚠️ Financial data is for informational purposes only. Not investment advice. Prices may be delayed.
Indication
Polycythemia vera (PV) — phlebotomy-dependent
Key Notes
REVIVE Phase 3 trial topline data expected H2 2026. Rusfertide is a hepcidin mimetic for polycythemia vera. Company guided H2 2026. NDA submission planned following positive data.
⚠️ Not Investment Advice: This information is provided for educational purposes only.
PDUFA dates are FDA target action dates, not guaranteed approval dates. The FDA may extend the review period,
issue Complete Response Letters, or take unexpected actions. Probability of approval scores are based on
historical base rates and do not account for drug-specific factors. Always consult a financial advisor
before making investment decisions.
Discussion
Share your analysis, research, or questions about this catalyst. No account required.